Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogen flavoenzymes are a diverse class of proteins that utilize flavin adenine dinucleotide (FAD) or flavin mononucleotide (FMN) as essential cofactors to catalyze a wide range of redox reactions. These enzymes are critical for the survival, virulence, and metabolic adaptation of various bacteria, fungi, and protozoan parasites, often participating in the electron transport chain, DNA repair, and the maintenance of redox homeostasis. Because many pathogen flavoenzymes possess structural and mechanistic features distinct from their human counterparts, they are highly attractive targets for the development of selective antimicrobial and antiparasitic agents. Drugs targeting these enzymes typically function either by direct inhibition of the catalytic site, such as Plasmodium falciparum dihydroorotate dehydrogenase inhibitors for malaria, or by acting as prodrugs that are activated by the flavoenzyme into toxic intermediates, as seen with nitrofurans and nitroimidazoles. The therapeutic potential of this class is underscored by its involvement in essential pathways that, when disrupted, lead to pathogen death or increased susceptibility to host immune responses.
Inhibition of essential metabolic redox reactions or prodrug activation via enzymatic reduction to generate reactive cytotoxic species.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen flavoenzyme (PFE).